Literature DB >> 17470132

Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations.

Y P Goldberg1, J MacFarlane, M L MacDonald, J Thompson, M-P Dube, M Mattice, R Fraser, C Young, S Hossain, T Pape, B Payne, C Radomski, G Donaldson, E Ives, J Cox, H B Younghusband, R Green, A Duff, E Boltshauser, G A Grinspan, J H Dimon, B G Sibley, G Andria, E Toscano, J Kerdraon, D Bowsher, S N Pimstone, M E Samuels, R Sherrington, M R Hayden.   

Abstract

Congenital indifference to pain (CIP) is a rare condition in which patients have severely impaired pain perception, but are otherwise essentially normal. We identified and collected DNA from individuals from nine families of seven different nationalities in which the affected individuals meet the diagnostic criteria for CIP. Using homozygosity mapping and haplotype sharing methods, we narrowed the CIP locus to chromosome 2q24-q31, a region known to contain a cluster of voltage-gated sodium channel genes. From these prioritized candidate sodium channels, we identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7. The mutations completely co-segregated with the disease phenotype, and nine of these SCN9A mutations resulted in truncation and loss-of-function of the Nav1.7 channel. These genetic data further support the evidence that Nav1.7 plays an essential role in mediating pain in humans, and that SCN9A mutations identified in multiple different populations underlie CIP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470132     DOI: 10.1111/j.1399-0004.2007.00790.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  124 in total

1.  Extending the clinical spectrum of pain channelopathies.

Authors:  Henry Houlden
Journal:  Brain       Date:  2012-02       Impact factor: 13.501

Review 2.  Pain disorders and erythromelalgia caused by voltage-gated sodium channel mutations.

Authors:  Ron Dabby
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

3.  A nonsense mutation in the SCN9A gene in congenital insensitivity to pain.

Authors:  Mazen Kurban; Muhammad Wajid; Yutaka Shimomura; Angela M Christiano
Journal:  Dermatology       Date:  2010-07-13       Impact factor: 5.366

4.  Overcoming obstacles to developing new analgesics.

Authors:  Clifford J Woolf
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

5.  Candidate hippocampal biomarkers of susceptibility and resilience to stress in a rat model of depression.

Authors:  Kim Henningsen; Johan Palmfeldt; Sofie Christiansen; Isabel Baiges; Steffen Bak; Ole Nørregaard Jensen; Niels Gregersen; Ove Wiborg
Journal:  Mol Cell Proteomics       Date:  2012-02-06       Impact factor: 5.911

6.  Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a).

Authors:  Natali A Minassian; Alan Gibbs; Amy Y Shih; Yi Liu; Robert A Neff; Steven W Sutton; Tara Mirzadegan; Judith Connor; Ross Fellows; Matthew Husovsky; Serena Nelson; Michael J Hunter; Mack Flinspach; Alan D Wickenden
Journal:  J Biol Chem       Date:  2013-06-12       Impact factor: 5.157

Review 7.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 8.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

9.  Ranolazine attenuates behavioral signs of neuropathic pain.

Authors:  Harry J Gould; Colleen Garrett; Renee R Donahue; Dennis Paul; Ivan Diamond; Bradley K Taylor
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

10.  Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling.

Authors:  Albert G Remacle; Sonu Kumar; Khatereh Motamedchaboki; Piotr Cieplak; Swathi Hullugundi; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  J Biol Chem       Date:  2015-08-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.